{"title":"不要放松警惕:COVID-19疫苗接种后单侧腋窝淋巴结病影像学评价1例报告","authors":"Chandan Tiwari, Deepa Grewal","doi":"10.25259/crcr_13_2022","DOIUrl":null,"url":null,"abstract":"There is significant increase in number of COVID-19 vaccination recipients around the world to contain the COVID-19 pandemic. However, one of the most common adverse effects of COVID-19 vaccine is unilateral axillary lymphadenopathy. There is variable time for complete resolution of reactive lymphadenopathy. It has, therefore, lead to diagnostic dilemma for oncological imaging for breast cancer in recent times. We describe a case of unilateral axillary lymphadenopathy in a patient following COVID-19 vaccination, which was finally proven to be invasive carcinoma on histopathology.","PeriodicalId":419021,"journal":{"name":"Case Reports in Clinical Radiology","volume":"193 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Do not let the guard down: A case report on imaging evaluation of unilateral axillary lymphadenopathy following COVID-19 vaccination\",\"authors\":\"Chandan Tiwari, Deepa Grewal\",\"doi\":\"10.25259/crcr_13_2022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"There is significant increase in number of COVID-19 vaccination recipients around the world to contain the COVID-19 pandemic. However, one of the most common adverse effects of COVID-19 vaccine is unilateral axillary lymphadenopathy. There is variable time for complete resolution of reactive lymphadenopathy. It has, therefore, lead to diagnostic dilemma for oncological imaging for breast cancer in recent times. We describe a case of unilateral axillary lymphadenopathy in a patient following COVID-19 vaccination, which was finally proven to be invasive carcinoma on histopathology.\",\"PeriodicalId\":419021,\"journal\":{\"name\":\"Case Reports in Clinical Radiology\",\"volume\":\"193 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Clinical Radiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/crcr_13_2022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Clinical Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/crcr_13_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Do not let the guard down: A case report on imaging evaluation of unilateral axillary lymphadenopathy following COVID-19 vaccination
There is significant increase in number of COVID-19 vaccination recipients around the world to contain the COVID-19 pandemic. However, one of the most common adverse effects of COVID-19 vaccine is unilateral axillary lymphadenopathy. There is variable time for complete resolution of reactive lymphadenopathy. It has, therefore, lead to diagnostic dilemma for oncological imaging for breast cancer in recent times. We describe a case of unilateral axillary lymphadenopathy in a patient following COVID-19 vaccination, which was finally proven to be invasive carcinoma on histopathology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
